Vaxart Inc (VXRT) is a biotechnology company listed on US.
Latest reported VXRT revenue for 2026-06-30 was $66.4M. Net income was -$8.3M. Revenue was up 69.3% from 2026-03-31 to 2026-06-30. VXRT currently screens at market cap $73.0M.
Use this VXRT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the VXRT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the VXRT SEC filings page. Lician reads the product cache first so this HTML stays unique to Vaxart Inc even when a live quote feed is slow.
Latest cached year on this hub. Full VXRT income, balance, and cash tables.